Parafibromin inhibits cancer cell growth and causes G1 phase arrest (Q24304063)

negative regulation of G1/S transition of mitotic cell cycle

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

Bart O Williams

11

Bart O

Williams

1 reference

26 November 2023

Bin Tean Teh

12

Bin Tean

Teh

1 reference

26 November 2023

Chun Zhang

1

Chun

Zhang

1 reference

26 November 2023

Dong Kong

2

Dong

Kong

1 reference

26 November 2023

Min-Han Tan

3

Min-Han

Tan

1 reference

26 November 2023

Donald L Pappas

4

Donald L Jr

Pappas

1 reference

26 November 2023

Peng-Fei Wang

5

Peng-Fei

Wang

1 reference

26 November 2023

Jindong Chen

6

Jindong

Chen

1 reference

26 November 2023

Leslie Farber

7

Leslie

Farber

1 reference

26 November 2023

Nian Zhang

8

Nian

Zhang

1 reference

26 November 2023

Han-Mo Koo

9

Han-Mo

Koo

1 reference

26 November 2023

Michael Weinreich

10

Michael

Weinreich

1 reference

26 November 2023

language of work or name

English

0 references

publication date

10 November 2006

0 references

number of pages

8

1 reference

Biochemical and Biophysical Research Communications

inferred from page(s)

published in

0 references

volume

350

0 references

page(s)

17-24

0 references

issue

1

0 references

cites work

WAF1, a potential mediator of p53 tumor suppression

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

[Genetics of endocrine tumours]

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Myc suppression of the p21 Cip1 Cdk inhibitor influences the outcome of the p53 response to DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Homocysteine induces programmed cell death in human vascular endothelial cells through activation of the unfolded protein response

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

A complex containing RNA polymerase II, Paf1p, Cdc73p, Hpr1p, and Ccr4p plays a role in protein kinase C signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

RNA polymerase II elongation factors of Saccharomyces cerevisiae: a targeted proteomics approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

The parafibromin tumor suppressor protein is part of a human Paf1 complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021

Loss of parafibromin expression in a subset of parathyroid adenomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2006.08.169

7 January 2021